AJ91 — Doccheck AG Cashflow Statement
0.000.00%
- €59.87m
- €42.88m
- €53.79m
- 98
- 82
- 57
- 95
Annual cashflow statement for Doccheck AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 13.8 | 16.6 | 10.4 | 3.54 | 6.61 |
Depreciation | |||||
Non-Cash Items | 1.2 | 0.072 | -1.59 | -0.51 | -0.191 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.25 | -8.23 | -5.75 | -0.593 | -1.25 |
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 11.5 | 10.9 | 5.95 | 7.51 | 7.64 |
Capital Expenditures | -3.42 | -4.02 | -6.45 | -1.89 | -1.13 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 2.51 | -0.29 | 1.59 | -0.04 | -0.342 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.911 | -4.31 | -4.86 | -1.93 | -1.48 |
Financing Cash Flow Items | 0.178 | -0.089 | 0.049 | 0.081 | -0.002 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.11 | -5.95 | -5.89 | -4.6 | -3.5 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.53 | 0.675 | -4.8 | 0.976 | 2.66 |